Kun Nie

Kun Nie has a strong background in biostatistics and extensive experience in the pharmaceutical industry. They are currently working as the Executive Director Biostatistics at Kura Oncology, Inc. Prior to this, they held the position of Statistical Science Director at AstraZeneca. Kun also served as the Director of Biostatistics at Clindata Insight Inc, where they provided statistical leadership, consulted with clients, and supervised junior level statisticians. They worked at Amgen for several years, first as a Biostatistics Sr. Manager and later as a Biostatistics Manager, overseeing statistical activities for various studies and playing a pivotal role in successful FDA filings. Prior to joining Amgen, Kun worked as a Statistician at Boehringer Ingelheim Pharmaceuticals. They also have research experience as a Graduate Student Researcher at UCLA, where they designed statistical analysis plans for clinical trials in the field of substance abuse research. Overall, Kun Nie's work experience showcases their expertise in biostatistics and their ability to provide statistical leadership and support drug development programs.

Kun Nie received a Ph.D. in Biostatistics from UCLA, completing the program from 2000 to 2004. Prior to that, from 1997 to 2000, Kun Nie attended Peking University, where they obtained an M.S. degree in Statistics. Kun Nie's education journey began at Tsinghua University, where they pursued an M.S. in Mathematics from 1993 to 1997.